A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and Haemophilus influenzae type b. Areas Covered To evaluate the immunogenicity and reactogenicity (saf...
| Main Authors: | , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Taylor & Francis Group
2023-12-01
|
| 叢編: | Expert Review of Vaccines |
| 主題: | |
| 在線閱讀: | http://dx.doi.org/10.1080/14760584.2023.2161519 |